4.3450
23-May-25 11:17:02
15 minutes delayed
Stocks
-0.0350
-0.80%
Today's range
4.2400 - 4.3700
ISIN
N/A
Source
NASDAQ
Verve Therapeutics Reports Preclinical Data Demonstrating Potent Editing of ANGPTL3 Gene Using Proprietary GalNAc-LNP Delivery Technology in Non-Human Primates
09 Nov 2021 03:30:00 By Nasdaq GlobeNewswire
Verve Therapeutics to Participate in the Jefferies Gene Therapy/Editing Summit
21 Oct 2021 03:30:00 By Nasdaq GlobeNewswire